The American Cancer Society (ACS), the American Society for Colposcopy and Cervical Pathology (ASCCP), and the American Society for Clinical Pathology (ASCP) have released new guidelines for the prevention and early detection of cervical cancer. The guidelines generally advise a reduction in the number of tests women get over their lifetime to better ensure that they receive the benefits of testing while minimizing the harms, and include a preference for co-testing using the Pap test and HPV test for women age ages 30 to 65. The New ACS-ASCCP-ASCP Cervical Cancer Screening Guidelines article may be accessed through the Journal of Lower Genital Tract Disease.
See the Powerpoint Presentation on the 2012 Cervical Cancer Screening Recommendations.
For reprinting of ASCCP material please see Reprint Permissions.
Advanced Colposcopy: Implementing the Guidelines through Case-Based Images
Apply the management guidelines in various clinical scenarios with iteration of the underlying clinical and basic science to specific cases and patient populations.
Cases Using Consensus Guidelines
A focused topic for the Treatment of Cervical Intraepithelia Neoplasia attendees
2012 Consensus Conference Findings
Updated Consensus Guidelines for Managing Abnormal Cervical Cancer Screening Tests and Cancer Precursors
Impact of LAST on the ASCCP Management Guidelines
Progress and Pitfalls in Uptake of New Cervical Cancer Screening Guidelines
New Cervical Cancer Screening Guidelines Addressing Barriers to Adoption
A sought after Lunch With The Professor session
Cervical Cancer Screening
A special event hosted by Roche Diagnostics Corporation with an emphasis on cervical cancer screening guidelines, ATHENA Study design, and will include ASC-US triage and management of the hrHPV positive woman.